Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-010069
Filing Date
2025-04-03
Accepted
2025-04-03 19:15:41
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 form4-04032025_110438.html 4  
1 form4-04032025_110438.xml 4 4584
  Complete submission text file 0001415889-25-010069.txt   6266
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 15660 CHERRY BLOSSOM RD FRISCO TX 75033
Business Address
Sayad Pierre Sargis (Reporting) CIK: 0002043395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 25811519